Clinica Ematologia di UdineUdine, Italy
NA
(1498877) XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling
Friday, October 6, 202311:35 AM – 11:40 AM EDT
(1552495) Impact of COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study.
Friday, October 6, 20231:50 PM – 1:55 PM EDT
(1553031) Constituitive VLA-4 activation is linked to BCR autonomous signaling in circulating CLL cells and promotes pro-survival signals through soluble blood-borne VCAM-1 binding
Saturday, October 7, 20233:05 PM – 3:15 PM EDT
